- ICH GCP
- EU-Register für klinische Studien
Neueste Versuche
EudraCT Number: 2006-001763-36 | Sponsor Protocol Number: CSPP100A2347 | Start Date: 2006-12-04 | ||||||
Sponsor Name: Novartis Pharma Services AG | ||||||||
Full Title: A randomized, double-blind, parallel-group, placebo-controlled, multinational clinical trial to evaluate the efficacy of Aliskiren and valsartan versus placebo in lowering levels on NT-proBNP in st... | ||||||||
Medical condition: Hypertension | ||||||||
|
||||||||
Population Age: | Gender: Male, Female | |||||||
Trial protocol: NL (Completed) SE (Completed) CZ (Completed) BE (Completed) DE (Completed) HU (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2006-004632-69 | Sponsor Protocol Number: P060309 | Start Date: 2006-12-04 | |||||||||||
Sponsor Name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Polymorphismes du gène codant pour le cytochrome 2C19 et réponse au clopidogrel chez le sujet sain | |||||||||||||
Medical condition: volontaire sain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002060-26 | Sponsor Protocol Number: 1401201 | Start Date: 2006-12-04 | |||||||||||
Sponsor Name: Intendis GmbH | |||||||||||||
Full Title: A double-blind, randomized, vehicle-controlled, 6-week exploratory multicenter pilot study of the efficacy and safety of Azelaic Acid (AzA) 15% gel in the topical treatment of mild to moderate seb... | |||||||||||||
Medical condition: Patients with mild to moderate seborrheic dermatitis of the facial area and meeting the specific eligibility criteria | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004465-33 | Sponsor Protocol Number: Cox052006 | Start Date: 2006-12-04 | |||||||||||
Sponsor Name: Eero Kaasinen | |||||||||||||
Full Title: Oral Celecoxib combined with BCG instillation therapy in treatment of carcinoma in situ (CIS), TaG3 and T1 disease of urinary bladder | |||||||||||||
Medical condition: invasive bladder cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003577-27 | Sponsor Protocol Number: A6631007 | Start Date: 2006-12-01 | |||||||||||
Sponsor Name: Pfizer Luxembourg SARL Branch Office Estonia | |||||||||||||
Full Title: A 12-WEEK, PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED STUDY TO INVESTIGATE THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF PH-797804, ADMINISTERED ORALLY ONCE DAILY IN SUBJECTS WITH ACTIVE... | |||||||||||||
Medical condition: Treatment of rheumatoid arthritis (RA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) CZ (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002361-39 | Sponsor Protocol Number: BAY 79-4998 / 12331 | Start Date: 2006-12-01 | |||||||||||
Sponsor Name: Bayer Vital GmbH | |||||||||||||
Full Title: A 4-week, open-label, multicenter, urodynamic pilot study to explore the efficacy, tolerability and safety of darifenacin (7.5 mg with up-titration to 15 mg) in patients with multiple sclerosis and... | |||||||||||||
Medical condition: Neurogenic overactive bladder disaese in patients with multiple sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003121-82 | Sponsor Protocol Number: 4351 | Start Date: 2006-12-01 | |||||||||||
Sponsor Name: University Hospital Southampton NHS Foundation Trust | |||||||||||||
Full Title: A prospective randomised open label trial of oxaliplatin / irinotecan plus fluorouracil versus oxaliplatin / irinotecan plus fluorouracil and cetuximab pre and post operatively in patients with res... | |||||||||||||
Medical condition: Colorectal Cancer Liver Metastasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001446-16 | Sponsor Protocol Number: F05-TdI-301 | Start Date: 2006-12-01 | ||||||
Sponsor Name: Sanofi Pasteur MSD | ||||||||
Full Title: Comparison of the immunogenicity and safety of a combined adsorbed low dose diphtheria, tetanus and inactivated poliomyelitis vaccine (REVAXIS®) with a combined diphtheria, tetanus and inactivated ... | ||||||||
Medical condition: Not applicable - Healthy volunteers - 6 year-old child | ||||||||
|
||||||||
Population Age: Children, Under 18 | Gender: Male, Female | |||||||
Trial protocol: FR (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2006-001608-35 | Sponsor Protocol Number: HUM-04-80 | Start Date: 2006-12-01 | |||||||||||
Sponsor Name: Dr. Valérie gangji | |||||||||||||
Full Title: TREATMENT OF SCIATICA BY ADALIMUMAB INJECTION : A RANDOMIZED, DOUBLE BLIND CONTROLLED TRIAL. | |||||||||||||
Medical condition: To determine the efficacy of adalimumab in disc herniation-induced sciatica in a controlled randomised double blind pilot study. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002245-36 | Sponsor Protocol Number: MKC-TI-103 | Start Date: 2006-12-01 | |||||||||||
Sponsor Name: MannKind Corporation | |||||||||||||
Full Title: A Phase 3, 24-Week, Multi-Center, Open-Label, Randomized, Controlled Trial Comparing the Efficacy and Safety of Prandial Inhalation of Technosphere®/Insulin in Combination with Metformin or Technos... | |||||||||||||
Medical condition: Diabetes mellitus type II | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |